期刊文献+

中华医学会开展“流感教育宣传周”活动的经验和体会

Experience of “Flu Education Dissemination Week”Activity Held by Chinese Midical Association
下载PDF
导出
作者 张圣芬
机构地区 中华医学会
出处 《中国健康教育》 2004年第8期736-737,共2页 Chinese Journal of Health Education
  • 相关文献

参考文献4

二级参考文献28

  • 1[1]Massarella JW,He GZ,Dorr A,et al.The pharmacokinetics and tolerability of the oral neuraminidase inhibitor oseltamivir in healthy adult and elderly volunteers[J].J Clin Pharmacol,2000,40:836.
  • 2[2]Centers for Disease Control and Prevention.Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices(ACIP)[C].MMWR Morb Mortal Wkly Rep,2000,49(RR-03):1.
  • 3[3]Musich SA,Burton WN,Edington DW.Costs and benefits of prevention and disease management[J].Dis Manage Health Outcomes,1999,5:153.
  • 4[4]He G,Massarella J,Ward P.Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802[J].Clin Pharmacokinet,1999,37:471.
  • 5[5]Hay AJ.The action of adamantanamines against influenza A viruses: inhibition of the M2 ion channel protein[J].Semin Virol,1992,3:21.
  • 6[6]Centers for Disease Control and Prevention.Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices(ACIP)[C].MMWR Morb Mortal Wkly Rep,1998,47(RR-0):1.
  • 7[7]Gubareva LV,Kaiser L,Hayden FG.Influenza virus neuraminidase inhibitors[J].Lancet,2000,355:827.
  • 8[8]McClellan K,Perry CM.Oseltamivir: a review of its use in influenza[J].Drugs,2001,61(2):263.
  • 9[9]Kim CU,Lew W,Williams MA,et al.Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design,synthesis,and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity[J].J Am Chem Soc,1997,119:681.
  • 10[10]Varghese JN,Colman PM.Three-dimensional structure of the neuraminidase of influenza virus A/Tokyo/3/67 at 2.2 A resolution[J].J Mol Biol,1991,221:473.

共引文献114

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部